Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials. (2022)

First Author: Cui W

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.breast.2022.05.002

PubMed Identifier: 35597179

Publication URI: http://europepmc.org/abstract/MED/35597179

Type: Journal Article/Review

Volume: 64

Parent Publication: Breast (Edinburgh, Scotland)

ISSN: 0960-9776